FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938554433> ?p ?o ?g. }

• W2938554433 abstract "Herein, we describe the use of systemic immunotherapy for both locally advanced and metastatic conjunctival melanoma. Current treatments for advanced conjunctival melanoma typically result in poor local control leading to disfiguring orbital exenteration surgery. Locoregional spread of conjunctival malignant melanoma typically requires pre-auricular and cervical lymph node dissection with post-operative adjuvant radiation therapy. In addition, classic systemic chemotherapy has been unsuccessful in the treatment of metastatic disease.This is a retrospectively analyzed clinical case series of 5 patients with biopsy proven conjunctival melanoma who were treated with checkpoint inhibition therapy. Of these, 3 patients were treated for residual ocular disease present after failing multiple local therapies and refusing orbital exenteration surgery and two (with local ocular control) for metastatic conjunctival melanoma. Both those with locally advanced disease and patients with metastatic disease received an anti-PD1 agent in combination with another immunotherapeutic agent. All 5 were given multiple cycles of systemic anti-PD1 therapy, 1 was initially treated with single agent ipilimumab (3 mg/kg) prior to approval of anti-PD1 agents and two received interferon eye drops. As part of each ophthalmic examination, photographs of all conjunctival and eyelid surfaces were obtained. Systemic evaluations involved initial staging scans as well as periodic re-imaging.All cases have shown responses. Of the 2 complete responses, 1 was a patient with systemic disease. No patients developed ocular toxicity or loss of vision. However, systemic adverse effects included adrenal insufficiency, Grade-III colitis, Grade-II dermatitis, Grade-II hepatotoxicity and Grade-II pneumonitis.This report suggests that systemic immunotherapy with or without topical interferon is effective in treatment of malignant melanoma of the conjunctiva. Therefore, it can be considered for patients with advanced local conjunctival melanoma, those who refuse orbital exenteration surgery and those with systemic metastasis." @default.
• W2938554433 created "2019-04-25" @default.
• W2938554433 creator A5056507476 @default.
• W2938554433 creator A5082539797 @default.
• W2938554433 date "2019-03-25" @default.
• W2938554433 modified "2023-10-12" @default.
• W2938554433 title "Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series" @default.
• W2938554433 cites W1486226346 @default.
• W2938554433 cites W1904332237 @default.
• W2938554433 cites W1976587524 @default.
• W2938554433 cites W1986812000 @default.
• W2938554433 cites W1989121777 @default.
• W2938554433 cites W1992117589 @default.
• W2938554433 cites W1997527307 @default.
• W2938554433 cites W2015909326 @default.
• W2938554433 cites W2021012420 @default.
• W2938554433 cites W2046263696 @default.
• W2938554433 cites W2076276800 @default.
• W2938554433 cites W2086529225 @default.
• W2938554433 cites W2118349725 @default.
• W2938554433 cites W2166662937 @default.
• W2938554433 cites W2439631449 @default.
• W2938554433 cites W2462306953 @default.
• W2938554433 cites W2519469881 @default.
• W2938554433 cites W2572174216 @default.
• W2938554433 cites W2592149081 @default.
• W2938554433 cites W2612663769 @default.
• W2938554433 cites W2888633816 @default.
• W2938554433 cites W4211105541 @default.
• W2938554433 cites W4244800086 @default.
• W2938554433 doi "https://doi.org/10.1186/s40425-019-0555-7" @default.
• W2938554433 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6434860" @default.
• W2938554433 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30909967" @default.
• W2938554433 hasPublicationYear "2019" @default.
• W2938554433 type Work @default.
• W2938554433 sameAs 2938554433 @default.
• W2938554433 citedByCount "52" @default.
• W2938554433 countsByYear W29385544332019 @default.
• W2938554433 countsByYear W29385544332020 @default.
• W2938554433 countsByYear W29385544332021 @default.
• W2938554433 countsByYear W29385544332022 @default.
• W2938554433 countsByYear W29385544332023 @default.
• W2938554433 crossrefType "journal-article" @default.
• W2938554433 hasAuthorship W2938554433A5056507476 @default.
• W2938554433 hasAuthorship W2938554433A5082539797 @default.
• W2938554433 hasBestOaLocation W29385544331 @default.
• W2938554433 hasConcept C121608353 @default.
• W2938554433 hasConcept C126322002 @default.
• W2938554433 hasConcept C141071460 @default.
• W2938554433 hasConcept C143998085 @default.
• W2938554433 hasConcept C16005928 @default.
• W2938554433 hasConcept C185926286 @default.
• W2938554433 hasConcept C2777658100 @default.
• W2938554433 hasConcept C2777701055 @default.
• W2938554433 hasConcept C2778674544 @default.
• W2938554433 hasConcept C2779134260 @default.
• W2938554433 hasConcept C2780030458 @default.
• W2938554433 hasConcept C2780057760 @default.
• W2938554433 hasConcept C2781433595 @default.
• W2938554433 hasConcept C502942594 @default.
• W2938554433 hasConcept C509974204 @default.
• W2938554433 hasConcept C530470458 @default.
• W2938554433 hasConcept C71924100 @default.
• W2938554433 hasConceptScore W2938554433C121608353 @default.
• W2938554433 hasConceptScore W2938554433C126322002 @default.
• W2938554433 hasConceptScore W2938554433C141071460 @default.
• W2938554433 hasConceptScore W2938554433C143998085 @default.
• W2938554433 hasConceptScore W2938554433C16005928 @default.
• W2938554433 hasConceptScore W2938554433C185926286 @default.
• W2938554433 hasConceptScore W2938554433C2777658100 @default.
• W2938554433 hasConceptScore W2938554433C2777701055 @default.
• W2938554433 hasConceptScore W2938554433C2778674544 @default.
• W2938554433 hasConceptScore W2938554433C2779134260 @default.
• W2938554433 hasConceptScore W2938554433C2780030458 @default.
• W2938554433 hasConceptScore W2938554433C2780057760 @default.
• W2938554433 hasConceptScore W2938554433C2781433595 @default.
• W2938554433 hasConceptScore W2938554433C502942594 @default.
• W2938554433 hasConceptScore W2938554433C509974204 @default.
• W2938554433 hasConceptScore W2938554433C530470458 @default.
• W2938554433 hasConceptScore W2938554433C71924100 @default.
• W2938554433 hasIssue "1" @default.
• W2938554433 hasLocation W29385544331 @default.
• W2938554433 hasLocation W29385544332 @default.
• W2938554433 hasLocation W29385544333 @default.
• W2938554433 hasLocation W29385544334 @default.
• W2938554433 hasOpenAccess W2938554433 @default.
• W2938554433 hasPrimaryLocation W29385544331 @default.
• W2938554433 hasRelatedWork W2155654588 @default.
• W2938554433 hasRelatedWork W2285109017 @default.
• W2938554433 hasRelatedWork W2607780130 @default.
• W2938554433 hasRelatedWork W2903811712 @default.
• W2938554433 hasRelatedWork W2915045061 @default.
• W2938554433 hasRelatedWork W2938554433 @default.
• W2938554433 hasRelatedWork W2969738919 @default.
• W2938554433 hasRelatedWork W3035446385 @default.
• W2938554433 hasRelatedWork W3215044659 @default.
• W2938554433 hasRelatedWork W4292373623 @default.
• W2938554433 hasVolume "7" @default.
• W2938554433 isParatext "false" @default.
• W2938554433 isRetracted "false" @default.

• next